China headquartered WuXi Diagnostics has announced the plan to open its first U.S.-based research and diagnostic testing development facility in Rochester, Minnesota to accelerate esoteric diagnostic product development, and bring more personalized and accurate clinical diagnosis services for global patients.

To bring more personalized and accurate clinical diagnosis services for global patients.The new facility is located in One Discovery Square, a new health technology and life sciences center in Rochester.

The facility is expected to open before the end of the year and will serve as a center for clinical diagnostic testing optimization and development.

"Our new facility will directly contribute to our further cooperation with Mayo Clinic," says Jason Liu, Ph.D., Chief Executive Officer of WuXi Diagnostics. "It will leverage WuXi Diagnostics' research and development capability and Mayo Clinic's advanced clinical practice to accelerate esoteric diagnostic product development and to transform discoveries into diagnostic tests that will benefit all."

WuXi Diagnostics' researchers and technicians will leverage this facility to optimize existing diagnostic tests and to collaborate in the development of new diagnostic tests with Mayo Clinic's Department of Laboratory Medicine and Pathology, specifically its Advanced Diagnostics Laboratory.

-----------------------------------------------------------------------
Editor's Note: For any copyright disputes involving the content,
please email: Julia.Zhang@ubmsinoexpo.com to delete.